18f-FDG-Pet-Based Radiomics Signature Predicts MGMT Promoter Methylation Status in Primary Diffuse Glioma

Cancer Imaging - United Kingdom
doi 10.1186/s40644-019-0246-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Optimized Feature Extraction for Radiomics Analysis of 18f-FDG-Pet Imaging

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

Personalized Treatment Strategies in Glioblastoma: MGMT Promoter Methylation Status

OncoTargets and Therapy
OncologyPharmacology
2013English

18f-FDG PET in Detecting Primary Breast Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2007English

Predictive Power of a Radiomic Signature Based on 18f-FDG PET/CT Images for EGFR Mutational Status in NSCLC

Frontiers in Oncology
Cancer ResearchOncology
2019English

A Novel DNA Methylation-Based Signature Can Predict the Responses of MGMT Promoter Unmethylated Glioblastomas to Temozolomide

Frontiers in Genetics
GeneticsMolecular Medicine
2019English

Recurrent Glioma and Crossed Cerebellar Diaschisis in a Patient Examined With 18f-Dopa and 18f-FDG PET/CT

Clinical Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2012English

18f-FDG PET Scanning in Pulmonary Amyloidosis

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2014English

Evaluation of 18f-FDG PET and MRI Associations in Pediatric Diffuse Intrinsic Brain Stem Glioma: A Report From the Pediatric Brain Tumor Consortium

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2011English

Role of 18F FDG PET in Differentiating Benign and Malignant Primary Bone Tumors

Bangladesh Journal of Nuclear Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy